
News|Articles|December 16, 2025
A look into the volume of Quest lab data for breast cancer research
Author(s)Quest Diagnostics
This datasheet illustrates how Quest Diagnostics' extensive de-identified lab data can be leveraged to accelerate and optimize clinical trials for breast cancer research. Researchers can use this real-world data to identify high concentrations of eligible patients, select optimal trial sites, find suitable principal investigators, and drive targeted patient recruitment efforts.
Trending on Applied Clinical Trials Online
1
ACT Brief: Bridging Site-Sponsor Data Gaps, Major Study Retraction, and TNBC First-Line Approval
2
ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion
3
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
4
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
5